Variant report
Variant | nsv892309 |
---|---|
Chromosome Location | chr9:10158866-10192290 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs77405222 | chr9:10159604-10159605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs73396361 | chr9:10159616-10159617 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs569243877 | chr9:10159638-10159639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs183284273 | chr9:10159675-10159676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs140108478 | chr9:10159680-10159681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs551322869 | chr9:10159681-10159682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs188798701 | chr9:10159687-10159688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs554109160 | chr9:10159720-10159721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs538163705 | chr9:10159736-10159737 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs112979909 | chr9:10159816-10159817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs190884917 | chr9:10159825-10159826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541088196 | chr9:10159827-10159828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs564278151 | chr9:10159858-10159859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs533135315 | chr9:10159867-10159868 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs550116159 | chr9:10159884-10159885 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs569888680 | chr9:10159897-10159898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs529168442 | chr9:10159906-10159907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs549147034 | chr9:10159990-10159991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs377345072 | chr9:10159999-10160000 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs182737361 | chr9:10160018-10160019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs575015121 | chr9:10160019-10160020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs534794130 | chr9:10160028-10160029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs370898843 | chr9:10160057-10160058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs557800374 | chr9:10160066-10160067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs571522033 | chr9:10160103-10160104 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs537280370 | chr9:10160109-10160110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs557507741 | chr9:10160196-10160197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs533633254 | chr9:10160200-10160201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs554015554 | chr9:10164418-10164419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs184476840 | chr9:10164453-10164454 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs369089470 | chr9:10164463-10164464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs547593487 | chr9:10164465-10164466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs189037698 | chr9:10164490-10164491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs148722530 | chr9:10164501-10164502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs549952565 | chr9:10164520-10164521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs569985632 | chr9:10164534-10164535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs574078700 | chr9:10164540-10164541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs535585209 | chr9:10164554-10164555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs2382195 | chr9:10164807-10164808 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs189065267 | chr9:10164818-10164819 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs146395846 | chr9:10164864-10164865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs567644503 | chr9:10164893-10164894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs5896374 | chr9:10164894-10164895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs397966479 | chr9:10164906-10164907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs180895175 | chr9:10164912-10164913 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs561794703 | chr9:10164915-10164916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs527983172 | chr9:10164951-10164952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572155343 | chr9:10164957-10164958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs541267786 | chr9:10164972-10164973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs184013088 | chr9:10164978-10164979 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Lung adenocarcinoma | 17982442 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Attention deficit hyperactivity disorder | 19546859 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:10159600-10160200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
2 | chr9:10164400-10164600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
3 | chr9:10164800-10165400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr9:10164800-10166600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr9:10165000-10165400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr9:10165200-10165400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
7 | chr9:10165400-10167800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr9:10165400-10173600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr9:10166600-10167800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr9:10167200-10168000 | Enhancers | Fetal Brain Male | brain |
11 | chr9:10167600-10168000 | Enhancers | Fetal Heart | heart |
12 | chr9:10167800-10168200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
13 | chr9:10167800-10168600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
14 | chr9:10168000-10168400 | Weak transcription | Fetal Heart | heart |
15 | chr9:10168000-10173600 | Weak transcription | Fetal Brain Male | brain |
16 | chr9:10168400-10168600 | Enhancers | Fetal Heart | heart |
17 | chr9:10168600-10172000 | Weak transcription | Fetal Heart | heart |
18 | chr9:10172000-10174000 | Enhancers | Fetal Heart | heart |
19 | chr9:10173600-10174400 | Enhancers | Fetal Brain Male | brain |
20 | chr9:10173600-10174800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
21 | chr9:10173800-10174200 | Enhancers | Fetal Brain Female | brain |
22 | chr9:10186600-10187000 | Enhancers | Fetal Heart | heart |
23 | chr9:10187000-10189400 | Weak transcription | Fetal Heart | heart |
24 | chr9:10189400-10189600 | Enhancers | Fetal Heart | heart |
25 | chr9:10191400-10191600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
26 | chr9:10191800-10193000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |